Sign in

CIK 0001850119 · <br>Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842040295
Phone
215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
  1. 4 Shares withheld for taxes SVP Finance & Operations gave up 16,611 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 20,763 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award SVP Finance & Operations acquired 120,846 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 151,058 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Option exercise Chief Scientific Officer acquired 7,452 shares (option exercise)
  16. 4 Open-market sale Chief Scientific Officer sold 144,911 shares at an average $3.73 ($539,879)
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award VP Finance & Operations acquired 15,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Scientific Officer acquired 43,750 shares (grant or award)

Page 7 of 10 · 188 filings